To the Editor: On behalf of the Endocrine Society of Australia, I would like to endorse the views expressed by Stockigt that the Therapeutic Goods Administration (TGA)-approved information sources for thyroid-related medications are outdated.1 His examples are compelling evidence that statements within product information (PI) sources are inconsistent with current practice. The consequences of these statements range from confusing to potentially dangerous.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- Department of Medicine, Monash University, Alfred Hospital, Melbourne, VIC.
Correspondence: Leon.Bach@med.monash.edu.au
- 1. Stockigt JR. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications. Med J Aust 2007; 186: 76-79. <MJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.